Clinical outcome of initially unresectable pancreatic cancer patients: Conversion surgery after modified FOLFIRINOX or gemcitabine nab-paclitaxel

被引：0
|
作者：
Ushida, Yuta [1 ]
Inoue, Yosuke [1 ]
Ito, Hiromichi [1 ]
Ono, Yoshihiro [1 ]
Sato, Takafumi [1 ]
Takahashi, Yu [1 ]
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
725
引用
收藏
页数：1
相关论文
共 50 条
  • [21] FOLFIRINOX and Gemcitabine/nab-Paclitaxel Demonstrate Improved Survival in Locally Advanced Unresectable Pancreatic Adenocarcinoma
    Bednar, F.
    Ocuin, L.
    Steve, J.
    Zenati, M.
    Winters, S.
    Hogg, M.
    Bahary, N.
    Zeh, H., III
    Zureikat, A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S175 - S176
  • [22] FOLFIRINOX and gemcitabine/nab-paclitaxel efficacy in the treatment of locally advanced unresectable pancreatic adenocarcinoma.
    Bednar, Filip
    Ocuin, Lee Mayer
    Steve, Jennifer
    Zenati, Mazen S.
    Winters, Sharon
    Hogg, Melissa Ellen
    Bahary, Nathan
    Zeh, Herbert J.
    Zureikat, Amer H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [23] Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure
    Mita, Naoki
    Iwashita, Takuji
    Uemura, Shinya
    Yoshida, Kensaku
    Iwasa, Yuhei
    Ando, Nobuhiro
    Iwata, Keisuke
    Okuno, Mitsuru
    Mukai, Tsuyoshi
    Shimizu, Masahito
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [24] A Case of Unresectable Pancreatic Cancer With BRCA1 Gene Mutation Effectively Worked by Modified FOLFIRINOX After Gemcitabine Plus Nab-Paclitaxel Refractory
    Maesono, T.
    Nishioka, M.
    Sugiura, C.
    Kawai, K.
    Okano, N.
    Kobayashi, T.
    Nagashima, F.
    Shibahara, J.
    Sakamoto, Y.
    Furuse, Y.
    PANCREAS, 2019, 48 (10) : 1484 - 1484
  • [25] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer
    Kunzmann, Volker
    Herrmann, Ken
    Bluemel, Christina
    Kapp, Markus
    Hartlapp, Ingo
    Steger, Ulrich
    CASE REPORTS IN ONCOLOGY, 2014, 7 (03): : 648 - 655
  • [27] The Prognostic Marker of Unresectable Pancreatic Cancer Undergoing Gemcitabine/nab-Paclitaxel Chemotherapy
    Ohno, A.
    Fujimori, N.
    Suehiro, Y.
    Murakami, M.
    Matsumoto, K.
    Teramatsu, K.
    Kojima, F.
    Takamaysu, Y.
    Takaoka, T.
    Oono, M.
    Ogawa, Y.
    PANCREAS, 2019, 48 (10) : 1500 - 1500
  • [28] Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
    Peterson, Shawn L.
    Husnain, Muhammad
    Pollack, Terri
    Pimentel, Agustin
    Loaiza-Bonilla, Arturo
    Westendorf-Overley, Colleen
    Ratermann, Kelley
    Anthony, Lowell
    Desimone, Philip
    Goel, Gaurav
    Kudrimoti, Mahesh
    Dineen, Sean
    Tzeng, Ching-Wei D.
    Hosein, Peter J.
    ANTICANCER RESEARCH, 2018, 38 (07) : 4035 - 4039
  • [29] Outcomes of FOLFIRINOX (FFX) and gemcitabine plus nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study.
    Chan, Kelvin K.
    Guo, Helen
    Beca, Jaclyn Marie
    Redmond-Misner, Ruby
    Isaranuwatchai, Wanrudee
    Qiao, Lucy
    Earle, Craig
    Berry, Scott R.
    Biagi, James Joseph
    Welch, Stephen
    Meyers, Brandon
    Mittmann, Nicole
    Coburn, Natalie
    Pardhan, Aliya
    Arias, Jessica
    Gavura, Scott
    Kennedy, Erin Diane
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [30] Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1) (vol 31, pg 816, 2024)
    Naohiro, O.
    Manabu, K.
    Makoto, U.
    Xianjun, Y.
    Yosuke, I
    Shinichiro, T.
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2025, 32 (02) : 177 - 177
12345